The equine immune responses to infectious and allergic disease: A model for humans?

Molecular Immunology

Volumn 66, Issue 1, 2015, Pages 89-96

  Horohov, David W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Allergy; Equine; Immunity; Infectious disease

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE;

ALLERGIC DISEASE; EQUINE INFECTIOUS ANEMIA; EQUINE INFLUENZA; HERPESVIRIDAE; HORSE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; INFECTION; INSECT BITE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHODOCOCCUS HOAGII; ANIMAL; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; HORSES; HUMANS; HYPERSENSITIVITY; INFECTION; MICE;

EID: 84925503455     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.09.020     Document Type: Review

References (185)

1. Adams A.A., Katepalli M.P., Kohler K., Reedy S.E., Stilz J.P., Vick M.M., Fitzgerald B.P., Lawrence L.M., Horohov D.W. Effect of body condition, body weight and adiposity on inflammatory cytokine responses in old horses. Vet. Immunol. Immunopathol. 2009, 127:286-294.
2. Adams A.A., Sturgill T.L., Breathnach C.C., Chambers T.M., Siger L., Minke J.M., Horohov D.W. Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection. Vet. Immunol. Immunopathol. 2011, 139:128-140.
3. Adkins B., Bu Y., Guevara P. Murine neonatal CD4+ lymph node cells are highly deficient in the development of antigen-specific Th1 function in adoptive adult hosts. J. Immunol. 2002, 169:4998-5004.
4. Adkins B., Du R.-Q. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J. Immunol. 1998, 160:4217-4224.
5. Adkins B., Hamilton K. Freshly isolated, murine neonatal T cells produce IL-4 in response to anti-CD3 stimulation. J. Immunol. 1992, 149:3448-3455.
6. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 2004, 4:553-564.
7. Aggarwal N., Holmes M.A. Characterisation of equine T helper cells: demonstration of Th1- and Th2-like cells in long-term equine T-cell cultures. Res. Vet. Sci. 1999, 66:277-279.
8. Aharonson-Raz K., Lohmann K.L., Townsend H.G., Marques F., Singh B. Pulmonary intravascular macrophages as proinflammatory cells in heaves, an asthma-like equine disease. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2012, 303:L189-L198.
9. Ainsworth D.M., Appleton J.A., Antczak D.F., Santiago M.A., Aviza G. IgG antibody responses to an inhaled antigen in horses with "heaves" (recurrent airway obstruction). Vet. Immunol. Immunopathol. 2002, 84:169-180.
10. Allen G., Yeargan M., Costa L.R., Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 1995, 69:606-612.
11. Allen G.P., O'Callaghan D.J., Randall C.C. Genetic relatedness of equine herpesvirus types 1 and 3. J. Virol. 1977, 24:761-767.
12. Andersson L.S., Swinbune J.E., Meadows J.R.S., Brostrom H., Eriksson S., Fikse W.F., Frey R., Sundquist M., Tseng C.T., Mikko S., Lindgren G. The same ELA class II risk factors confer equine insect bite hypersensitivity in two distinct populations. Immunogenetics 2012, 64:201-208.
13. Bai Y., Tong T.G., Zhang W.J., Xu S.L., Wang Q., Liu G.L., Wu D.L. Development of sandwich ELISA for equine interferon-gamma detection. Chin. J. Cell. Mol. Immunol. 2008, 24:464-466.
14. Barrandeguy M., Vissani A., Olguin C., Barbara G., Valenzuela H., Becerra L., Tordoya M., Mino S., Thiry E. Experimental infection with equid herpesvirus 3 in seronegative and seropositive mares. Vet. Microbiol. 2012, 160:319-326.
15. Beadle R.E., Horohov D.W., Gaunt S.D. Interleukin-4 and interferon-gamma gene expression in summer pasture-associated obstructive pulmonary disease affected horses. Equine Vet. J. 2002, 34:389-394.
16. Bell S.A., Balasuriya U.B., Gardner I.A., Barry P.A., Wilson W.D., Ferraro G.L., MacLachlan N.J. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals. Vet. Microbiol. 2006, 116:249-257.
17. Bogaert P., Tournoy K.G., Naessens T., Grooten J. Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma. Am. J. Pathol. 2009, 174:3-13.
18. Brazil T.J., Dagleish M.P., McGorum B.C., Dixon P.M., Haslett C., Chilvers E.R. Kinetics of pulmonary neutrophil recruitment and clearance in a natural and spontaneously resolving model of airway inflammation. Clin. Exp. Allergy 2005, 35:854-865.
19. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., Horohov D.W. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 2006, 112:199-209.
20. Brinkmeyer-Langford C.L., Cai J.J., Gill C.A., Skow L.C. Microsatellite variation in the equine MHC. Anim. Genet. 2013, 44:267-275.
21. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., MacRae S., Lewis N.S., Paillot R., Zanoni R., Meier H., Griffiths L.A., Daly J.M., Tiwari A., Chambers T.M., Newton J.R., Elton D.M. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet. Microbiol. 2009, 138:41-52.
22. Bureau F., Delhalle S., Bonizzi G., Fievez L., Dogne S., Kirschvink N., Vanderplasschen A., Merville M.P., Bours V., Lekeux P. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J. Immunol. 2000, 165:5822-5830.
23. Burton A.B., Wagner B., Erb H.N., Ainsworth D.M. Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals. Vet. Immunol. Immunopathol. 2009, 132:122-128.
24. Cardwell J., Smith K., Newton R., Blunden T., Bestbier M., Whitwell K. EHV paralytic disease in the south of England. Vet. Rec. 2003, 152:441-442.
25. Carrade Holt D.D., Wood J.A., Granick J.L., Walker N.J., Clark K.C., Borjesson D.L. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source. Stem Cells Dev. 2014, 23:1258-1265.
26. Chaffin M.K., Cohen N.D., Martens R.J., Edwards R.F., Nevill M. Foal-related risk factors associated with development of Rhodococcus equi pneumonia on farms with endemic infection. J. Am. Vet. Med. Assoc. 2003, 223:1791-1799.
27. Chaffin M.K., Cohen N.D., Martens R.J., Edwards R.F., Nevill M., Smith R. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection. Vet. Immunol. Immunopathol. 2004, 100:33-48.
28. Chambers T.M. A brief introduction to equine influenza and equine influenza viruses. Methods Mol. Biol. 2014, 1161:365-370.
29. Chavatte-Palmer P., Duvaux-Ponter C.S., Clement F. Passive transfer of immunity in horses. Pferdeheilkunde 2001, 17:669-672.
30. Choi J.S., Jang A.S., Park J.S., Park S.W., Paik S.H., Park J.S., Uh S.T., Kim Y.H., Park C.S. Role of neutrophils in persistent airway obstruction due to refractory asthma. Respirology 2012, 17:322-329.
31. Chong Y.C., Duffus W.P., Field H.J., Gray D.A., Awan A.R., O'Brien M.A., Lunn D.P. The raising of equine colostrum-deprived foals; maintenance and assessment of specific pathogen (EHV-1/4) free status. Equine Vet. J. 1991, 23:111-115.
32. Cohen N.D., O'Conor M.S., Chaffin M.K., Martens R.J. Farm characteristics and management practices associated with development of Rhodococcus equi pneumonia in foals. J. Am. Vet. Med. Assoc. 2005, 226:404-413.
33. Cook R.F., Leroux C., Issel C.J. Equine infectious anemia and equine infectious anemia virus in 2013: a review. Vet. Microbiol. 2013, 167:181-204.
34. Cordeau M.E., Joubert P., Dewachi O., Hamid Q., Lavoie J.P. IL-4, IL-5 and IFN-gamma mRNA expression in pulmonary lymphocytes in equine heaves. Vet. Immunol. Immunopathol. 2004, 97:87-96.
35. Craigo J.K., Ezzelarab C., Cook S.J., Chong L., Horohov D., Issel C.J., Montelaro R.C. Envelope determinants of equine lentiviral vaccine protection. PLoS ONE 2013, 8:e66093.
36. Craigo J.K., Leroux C., Howe L., Steckbeck J.D., Cook S.J., Issel C.J., Montelaro R.C. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. J. Gen. Virol. 2002, 83:1353-1359.
37. Craigo J.K., Montelaro R.C. Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity. Viruses 2013, 5:2963-2976.
38. Cunningham F.M., Dunkel B. Equine recurrent airway obstruction and insect bite hypersensitivity: understanding the diseases and uncovering possible new therapeutic approaches. Vet. J. 2008, 177:334-344.
39. Dakin S.G., Dudhia J., Werling N.J., Werling D., Abayasekara D.R., Smith R.K. Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease. PLoS ONE 2012, 7:e48978.
40. Daly J.M., MacRae S., Newton J.R., Wattrang E., Elton D.M. Equine influenza: a review of an unpredictable virus. Vet. J. 2011, 189:7-14.
41. De Schauwer C., Van de Walle G.R., Van Soom A., Meyer E. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?. Vet. Q. 2013, 33:234-241.
42. Dearman R.J., Kimber I. Animal models of protein allergenicity: potential benefits, pitfalls and challenges. Clin. Exp. Allergy 2009, 39:458-468.
43. Debrue M., Hamilton E., Joubert P., Lajoie-Kadoch S., Lavoie J.P. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Vet. Immunol. Immunopathol. 2005, 105:25-31.
44. Dunowska M. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: Pathogenesis and epidemiology. N. Z. Vet. J. 2014, 62:179-188.
45. Eder C., Crameri R., Mayer C., Eicher R., Straub R., Gerber H., Lazary S., Marti E. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet. Immunol. Immunopathol. 2000, 73:241-253.
46. Fadok V.A. Update on equine allergies. Vet. Clin. North Am. Equine Pract. 2013, 29:541-550.
47. Fermaglich D.H., Horohov D.W. The effect of aging on immune responses. Vet. Clin. North Am. Equine Pract. 2002, 18:621-630. ix.
48. Ferris R.A., Frisbie D.D., McCue P.M. Use of mesenchymal stem cells or autologous conditioned serum to modulate the inflammatory response to spermatozoa in mares. Theriogenology 2014, 82:36-42.
49. Finlay C.M., Walsh K.P., Mills K.H. Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol. Rev. 2014, 259:206-230.
50. Flaminio M.J., Rush B.R., Davis E.G., Hennessy K., Shuman W., Wilkerson M.J. Characterization of peripheral blood and pulmonary leukocyte function in healthy foals. Vet. Immunol. Immunopathol. 2000, 73:267-285.
51. Florez H., Troen B.R. Fat and inflammaging: a dual path to unfitness in elderly people?. J. Am. Geriatr. Soc. 2008, 56:558-560.
52. Ford J.E., Home W.A., Gibson D.M. Light chain isotype regulation in the horse. Characterization of Ig kappa genes. J. Immunol. 1994, 153:1099-1111.
53. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
54. Franchini M., Gilli U., Akens M.K., Fellenberg R.V., Bracher V. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Vet. Immunol. Immunopathol. 1998, 66:53-65.
55. Fraser D.G., Bailey E. Polymorphism and multiple loci for the horse DQA gene. Immunogenetics 1998, 47:487-490.
56. Fu Z.F., Robinson A.J., Horner G.W., Dickinson L.G., Grimmett J.B., Marshall R.B. Respiratory disease in foals and the epizootiology of equine herpesvirus type 2 infection. N. Z. Vet. J. 1986, 34:152-155.
57. Fulop T., Le Page A., Fortin C., Witkowski J.M., Dupuis G., Larbi A. Cellular signaling in the aging immune system. Curr. Opin. Immunol. 2014, 29C:105-111.
58. Gerber V., Tessier C., Marti E. Genetics of upper and lower airway diseases in the horse. Equine Vet. J. 2014.
59. Giguere S., Prescott J.F. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet. Microbiol. 1997, 56:313-334.
60. Giguere S., Prescott J.F. Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction. Vet. Immunol. Immunopathol. 1999, 67:1-15.
61. Giguere S., Wilkie B.N., Prescott J.F. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect. Immun. 1999, 67:5041-5047.
62. Goehring L.S., Hussey G.S., Ashton L.V., Schenkel A.R., Lunn D.P. Infection of central nervous system endothelial cells by cell-associated EHV-1. Vet. Microbiol. 2011, 148:389-395.
63. Gold J.R., Perkins G.A., Erb H.N., Ainsworth D.M. Cytokine profiles of peripheral blood mononuclear cells isolated from septic and healthy neonatal foals. J. Vet. Intern. Med. 2007, 21:482-488.
64. Gold M.C., Donnelly E., Cook M.S., Leclair C.M., Lewinsohn D.A. Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation. Pediatr. Res. 2006, 60:34-37.
65. Grunig G., Barbis D.P., Zhang C.H., Davis W.C., Lunn D.P., Antczak D.F. Correlation between monoclonal antibody reactivity and expression of CD4 and CD8 alpha genes in the horse. Vet. Immunol. Immunopathol. 1994, 42:61-69.
66. Gustafson A.L., Tallmadge R.L., Ramlachan N., Miller D., Bird H., Antczak D.F., Raudsepp T., Chowdhary B.P., Skow L.C. An ordered BAC contig map of the equine major histocompatibility complex. Cytogenet. Genome Res. 2003, 102:189-195.
67. Hagen J., Hartnett C., Houchins J.P., Giguere S., Kalyuzhny A.E. Equine ELISPOT assay to study secretion of IFNgamma and IL-4 from peripheral blood mononuclear cells. Methods Mol. Biol. 2012, 792:39-45.
68. Halliwell R.E., McGorum B.C., Irving P., Dixon P.M. Local and systemic antibody production in horses affected with chronic obstructive pulmonary disease. Vet. Immunol. Immunopathol. 1993, 38:201-215.
69. Hammond S.A., Cook S.J., Lichtenstein D.L., Issel C.J., Montelaro R.C. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 1997, 71:3840-3852.
70. Hammond S.A., Issel C.J., Montelaro R.C. General method for the detection and in vitro expansion of equine cytolytic T lymphocytes. J. Immunol. Meth. 1998, 213:73-85.
71. Hamza E., Gerber V., Steinbach F., Marti E. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro. Immunology 2011, 134:292-304.
72. Hamza E., Torsteinsdottir S., Eydal M., Frey C.F., Mirkovitch J., Brcic M., Wagner B., Wilson A.D., Jungi T.W., Marti E. Increased IL-4 and decreased regulatory cytokine production following relocation of Icelandic horses from a high to low endoparasite environment. Vet. Immunol. Immunopathol. 2010, 133:40-50.
73. Hannant D., Mumford J.A. Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells. Vet. Immunol. Immunopathol. 1989, 21:327-337.
74. Hannant D., Mumford J.A., Jessett D.M. Duration of circulating antibody and immunity following infection with equine influenza virus. Vet. Rec. 1988, 122:125-128.
75. Harris S.P., Fujiwara N., Mealey R.H., Alperin D.C., Naka T., Goda R., Hines S.A. Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes. Microbiology 2010, 156:1836-1847.
76. Heimann M., Janda J., Sigurdardottir O.G., Svansson V., Klukowska J., von Tscharner C., Doherr M., Brostrom H., Andersson L.S., Einarsson S., Marti E., Torsteinsdottir S. Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: a possible role for regulatory T cells. Vet. Immunol. Immunopathol. 2011, 140:63-74.
77. Hellberg W., Wilson A.D., Mellor P., Doherr M.G., Torsteinsdottir S., Zurbriggen A., Jungi T., Marti E. Equine insect bite hypersensitivity: immunoblot analysis of IgE and IgG subclass responses to Culicoides nubeculosus salivary gland extract. Vet. Immunol. Immunopathol. 2006, 113:99-112.
78. Herszberg B., Ramos-Barbon D., Tamaoka M., Martin J.G., Lavoie J.P. Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling. J. Allergy Clin. Immunol. 2006, 118:382-388.
79. Hines S.A., Stone D.M., Hines M.T., Alperin D.C., Knowles D.P., Norton L.K., Hamilton M.J., Davis W.C., McGuire T.C. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes. Clin. Diagn. Lab. Immunol. 2003, 10:208-215.
80. Holbrook T.C., Tipton T., McFarlane D. Neutrophil and cytokine dysregulation in hyperinsulinemic obese horses. Vet. Immunol. Immunopathol. 2012, 145:283-289.
81. Horin P., Osickova J., Necesankova M., Matiasovic J., Musilova P., Kubickova S., Hubertova D., Vyskocil M., Rubes J. Single nucleotide polymorphisms of interleukin-1 beta related genes and their associations with infection in the horse. Dev. Biol. (Basel) 2008, 132:347-351.
82. Horin P., Smola J., Matiasovic J., Vyskocil M., Lukeszova L., Tomanova K., Kralik P., Glasnak V., Schroffelova D., Knoll A., Sedlinska M., Krenkova L., Jahn P. Polymorphisms in equine immune response genes and their associations with infections. Mamm. Genome 2004, 15:843-850.
83. Hormanski C.E., Truax R., Pourciau S.S., Folsom R.W., Horohov D.W. Induction of lymphokine-activated killer cells of equine origin: specificity for equine target, cells. Vet. Immunol. Immunopathol. 1992, 32:25-36.
84. Horohov D., Swiderski C., Robinson J., Klei T. Cytokine Production in Various Equine Disease Settings 1998, CAB International, London, UK. M.C. Horzinek, V.E.C.J. Schilns (Eds.).
85. Horohov D.W., Adams A.A., Chambers T.M. Immunosenescence of the equine immune system. J. Comp. Pathol. 2010, 142(Suppl. 1):S78-S84.
86. Horohov D.W., Beadle R.E., Mouch S., Pourciau S.S. Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction. Vet. Immunol. Immunopathol. 2005, 108:237-245.
87. Horowitz M.L., Cohen N.D., Takai S., Becu T., Chaffin M.K., Chu K.K., Magdesian K.G., Martens R.J. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J. Vet. Intern. Med. 2001, 15:171-175.
88. Ibrahim S., Saunders K., Kydd J.H., Lunn D.P., Steinbach F. Screening of anti-human leukocyte monoclonal antibodies for reactivity with equine leukocytes. Vet. Immunol. Immunopathol. 2007, 119:63-80.
89. Ishii S. Equine infectious anemia or swamp fever. Adv. Vet. Sci. Comp. Med. 1963, 19:263-298.
90. Ito T., Kawaoka Y. Host-range barrier of influenza A viruses. Vet. Microbiol. 2000, 74:71-75.
91. Jacks S., Giguere S., Crawford P.C., Castleman W.L. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 2007, 14:669-677.
92. Jensen-Waern M., Persson S.G., Nordengrahn A., Merza M., Fossum C. Temporary suppression of cell-mediated immunity in standardbred horses with decreased athletic capacity. Acta Vet. Scand. 1998, 39:25-33.
93. Kabelitz D., Marischen L., Oberg H.H., Holtmeier W., Wesch D. Epithelial defence by gamma delta T cells. Int. Arch. Allergy Immunol. 2005, 137:73-81.
94. Kabithe E., Hillegas J., Stokol T., Moore J., Wagner B. Monoclonal antibodies to equine CD14. Vet. Immunol. Immunopathol. 2010, 138:149-153.
95. Kachroo P., Ivanov I., Seabury A.G., Liu M., Chowdhary B.P., Cohen N.D. Age-related changes following in vitro stimulation with Rhodococcus equi of peripheral blood leukocytes from neonatal foals. PLOS ONE 2013, 8:e62879.
96. Kalemkerian P.B., Metz G.E., Peral-Garcia P., Echeverria M.G., Giovambattista G., Diaz S. ELA-DRA polymorphisms are not associated with Equine Arteritis Virus infection in horses from Argentina. Res. Vet. Sci. 2012, 93:1271-1273.
97. Kamath P.L., Getz W.M. Adaptive molecular evolution of the Major Histocompatibility Complex genes, DRA and DQA, in the genus Equus. BMC Evol. Biol. 2011, 11:128.
98. Katepalli M.P., Adams A.A., Lear T.L., Horohov D.W. The effect of age and telomere length on immune function in the horse. Dev. Comp. Immunol. 2008, 32:1409-1415.
99. Keggan A., Freer H., Rollins A., Wagner B. Production of seven monoclonal equine immunoglobulins isotyped by multiplex analysis. Vet. Immunol. Immunopathol. 2013, 153:187-193.
100. Kleiber C., McGorum B.C., Horohov D.W., Pirie R.S., Zurbriggen A., Straub R. Cytokine profiles of peripheral blood and airway CD4+ and CD8+ T lymphocytes in horses with recurrent airway obstruction. Vet. Immunol. Immunopathol. 2005, 104:91-97.
101. Kohler A.K., Stone D.M., Hines M.T., Byrne B.A., Alperin D.C., Norton L.K., Hines S.A. Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection. Infect. Immun. 2003, 71:6329-6337.
102. Kydd J.H., Townsend H.G., Hannant D. The equine immune response to equine herpesvirus-1: the virus and its vaccines. Vet. Immunol. Immunopathol. 2006, 111:15-30.
103. Laan M., Linden A. The IL-17 family of cytokines - applications in respiratory medicine and allergology. Recent Pat. Inflamm. Allergy Drug Discov. 2008, 2:82-91.
104. Lavoie J.P., Maghni K., Desnoyers M., Taha R., Martin J.G., Hamid Q.A. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am. J. Respir. Crit. Care Med. 2001, 164:1410-1413.
105. Leber R., Wiler R., Perryman L.E., Meek K. Equine SCID: mechanistic analysis and comparison with murine SCID. Vet. Immunol. Immunopathol. 1998, 65:1-9.
106. Leutenegger C.M., von Rechenberg B., Huder J.B., Zlinsky K., Mislin C., Akens M.K., Auer J., Lutz H. Quantitative real-time PCR for equine cytokine mRNA in nondecalcified bone tissue embedded in methyl methacrylate. Calcif. Tissue Int. 1999, 65:378-383.
107. Lewis M.J., Wagner B., Irvine R.M., Woof J.M. IgA in the horse: cloning of equine polymeric Ig receptor and J chain and characterization of recombinant forms of equine IgA. Mucosal Immunol. 2010, 3:610-621.
108. Liu C., Cook S.J., Craigo J.K., Cook F.R., Issel C.J., Montelaro R.C., Horohov D.W. Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies. Vet. Immunol. Immunopathol. 2014, 161:161-169.
109. Lonning S.M., Zhang W., McGuire T.C. Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses. J. Virol. 1999, 73:4257-4265.
110. Lunn D.P., Holmes M.A., Duffus W.P.H. Three monoclonal-antibodies identifying antigens on all equine lymphocytes-T, and two mutually exclusive lymphocyte-T subsets. Immunology 1991, 74:251-257.
111. Lunn D.P., Hussey S., Sebing R., Rushlow K.E., Radecki S.V., Whitaker-Dowling P., Youngner J.S., Chambers T.M., Holland R.E., Horohov D.W. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. J. Am. Vet. Med. Assoc. 2001, 218:900-906.
112. Ma G., Azab W., Osterrieder N. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4) - masters of co-evolution and a constant threat to equids and beyond. Vet. Microbiol. 2013, 167:123-134.
113. Maklad M.K., Ahmed M.M., Hussein H.M., el-Wakil M.R., el-Wakil H.S. Time factor and eosinophil count in relation to experimental Schistosoma mansoni infection. J. Egypt. Soc. Parasitol. 1994, 24:591-596.
114. Marchiori E., Muller N.L., de Mendonca R.G., Capone D., Souza A.S., Escuissato D.L., Gasparetto E.L., de Cerqueira E.M. Rhodococcus equi pneumonia in AIDS: high-resolution CT findings in five patients. Br. J. Radiol. 2005, 78:783-786.
115. Marodi L. Innate cellular immune responses in newborns. Clin. Immunol. 2006, 118:137-144.
116. Martens R.J., Fiske R.A., Renshaw H.W. Experimental subacute foal pneumonia induced by aerosol administration of Corynebacterium equi. Equine Vet. J. 1982, 14:111-116.
117. Marti E., Gerber V., Wilson A.D., Lavoie J.P., Horohov D., Crameri R., Lunn D.P., Antczak D., Bjornsdottir S., Bjornsdottir T.S., Cunningham F., Derer M., Frey R., Hamza E., Horin P., Heimann M., Kolm-Stark G., Olafsdottir G., Ramery E., Russell C., Schaffartzik A., Svansson V., Torsteinsdottir S., Wagner B. Report of the 3rd Havemeyer workshop on allergic diseases of the Horse, Holar, Iceland, June 2007. Vet. Immunol. Immunopathol. 2008, 126:351-361.
118. McGuire T.C., Fraser D.G., Mealey R.H. Cytotoxic T lymphocytes in protection against equine infectious anemia virus. Anim. Health Res. Rev. 2004, 5:271-276.
119. McMichael A.J., Koff W.C. Vaccines that stimulate T cell immunity to HIV-1: the next step. Nat. Immunol. 2014, 15:319-322.
120. McTaggart C., Penhale J., Raidala S.L. Effect of plasma transfusion on neutrophil function in healthy and septic foals. Aust. Vet. J. 2005, 83:499-505.
121. Merant C., Breathnach C.C., Kohler K., Rashid C., Van Meter P., Horohov D.W. Young foal and adult horse monocyte-derived dendritic cells differ by their degree of phenotypic maturity. Vet. Immunol. Immunopathol. 2009, 131:1-8.
122. Mienaltowski M.J., Huang L., Frisbie D.D., McIlwraith C.W., Stromberg A.J., Bathke A.C., Macleod J.N. Transcriptional profiling differences for articular cartilage and repair tissue in equine joint surface lesions. BMC Med. Genomics 2009, 2:60.
123. Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., Jessett D., Black L., Bublot M., Pardo M.C., Audonnet J.C. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Am. J. Vet. Res. 2007, 68:213-219.
124. Morens D.M., Taubenberger J.K. Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza and Other Respiratory Viruses 2010, 4:327-337.
125. Morresey P.R., Waldridge B.M. Successful treatment of Rhodococcus equi pneumonia in an adult horse. J. Vet. Intern. Med. 2010, 24:436-438.
126. Morton H.C. IgA Fc receptors in cattle and horses. Vet. Immunol. Immunopathol. 2005, 108:139-143.
127. Muirhead T.L., McClure J.T., Wichtel J.J., Stryhn H., Markham R.J., McFarlane D., Lunn D.P. The effect of age on the immune response of horses to vaccination. J. Comp. Pathol. 2010, 142(Suppl. 1):S85-S90.
128. Noronha L.E., Antczak D.F. Maternal immune responses to trophoblast: the contribution of the horse to pregnancy immunology. Am. J. Reprod. Immunol. 2010, 64:231-244.
129. Noronha L.E., Harman R.M., Wagner B., Antczak D.F. Generation and characterization of monoclonal antibodies to equine CD16. Vet. Immunol. Immunopathol. 2012, 146:135-142.
130. Nydegger U.E., Mohacsi P.J., Escher R., Morell A. Clinical use of intravenous immunoglobulins. Vox Sang. 2000, 78(Suppl. 2):191-195.
131. Orlando L., Ginolhac A., Zhang G., Froese D., Albrechtsen A., Stiller M., Schubert M., Cappellini E., Petersen B., Moltke I., Johnson P.L., Fumagalli M., Vilstrup J.T., Raghavan M., Korneliussen T., Malaspinas A.S., Vogt J., Szklarczyk D., Kelstrup C.D., Vinther J., Dolocan A., Stenderup J., Velazquez A.M., Cahill J., Rasmussen M., Wang X., Min J., Zazula G.D., Seguin-Orlando A., Mortensen C., Magnussen K., Thompson J.F., Weinstock J., Gregersen K., Roed K.H., Eisenmann V., Rubin C.J., Miller D.C., Antczak D.F., Bertelsen M.F., Brunak S., Al-Rasheid K.A., Ryder O., Andersson L., Mundy J., Krogh A., Gilbert M.T., Kjaer K., Sicheritz-Ponten T., Jensen L.J., Olsen J.V., Hofreiter M., Nielsen R., Shapiro B., Wang J., Willerslev E. Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse. Nature 2013, 499:74-78.
132. Outram A.K., Stear N.A., Bendrey R., Olsen S., Kasparov A., Zaibert V., Thorpe N., Evershed R.P. The earliest horse harnessing and milking. Science 2009, 323:1332-1335.
133. Paillot R., Grimmett H., Elton D., Daly J.M. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. Vet. Res. 2008, 39:21.
134. Paillot R., Hannant D., Kydd J.H., Daly J.M. Vaccination against equine influenza: quid novi?. Vaccine 2006, 24:4047-4061.
135. Patton K.M., McGuire T.C., Fraser D.G., Hines S.A. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect. Immun. 2004, 72:7073-7083.
136. Perryman L.E. Primary immunodeficiencies of horses. Vet. Clin. North Am. Equine Pract. 2000, 16:105-116. vii.
137. Prescott J.F. Rhodococcus equi: an animal and human pathogen. Clin. Microbiol. Rev. 1991, 4:20-34.
138. Pusterla N., David Wilson W., Madigan J.E., Ferraro G.L. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments. Vet. J. 2009, 180:279-289.
139. Pusterla N., Hussey S.B., Mapes S., Johnson C., Collier J.R., Hill J., Lunn D.P., Wilson W.D. Molecular investigation of the viral kinetics of equine herpesvirus-1 in blood and nasal secretions of horses after corticosteroid-induced recrudescence of latent infection. J. Vet. Intern. Med. 2010, 24:1153-1157.
140. Quinlivan M., Nelly M., Prendergast M., Breathnach C., Horohov D., Arkins S., Chiang Y.W., Chu H.J., Ng T., Cullinane A. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. Vaccine 2007, 25:7056-7064.
141. Raidal S.L., Love D.N., Bailey G.D., Rose R.J. Effect of single bouts of moderate and high intensity exercise and training on equine peripheral blood neutrophil function. Res. Vet. Sci. 2000, 68:141-146.
142. Regan D.P., Aarnio M.C., Davis W.S., Carmichael K.P., Vandenplas M.L., Lauderdale J.D., Moore P.A. Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis. Vet. Ophthalmol. 2011, 145-152.
143. Robinson N.E., Derksen F.J., Olszewski M.A., Buechner-Maxwell V.A. The pathogenesis of chronic obstructive pulmonary disease of horses. Br. Vet. J. 1996, 152:283-306.
144. Sanchez-Matamoros A., Kukielka D., De las Heras A.I., Sanchez-Vizcaino J.M. Development and evaluation of a SYBR Green real-time RT-PCR assay for evaluation of cytokine gene expression in horse. Cytokine 2013, 61:50-53.
145. Sanz M., Loynachan A., Sun L., Oliveira A., Breheny P., Horohov D.W. The effect of bacterial dose and foal age at challenge on Rhodococcus equi infection. Vet. Microbiol. 2013, 167:623-631.
146. Schaffartzik A., Hamza E., Janda J., Crameri R., Marti E., Rhyner C. Equine insect bite hypersensitivity: what do we know?. Vet. Immunol. Immunopathol. 2012, 147:113-126.
147. Schaffartzik A., Marti E., Crameri R., Rhyner C. Cloning, production and characterization of antigen 5 like proteins from Simulium vittatum and Culicoides nubeculosus, the first cross-reactive allergen associated with equine insect bite hypersensitivity. Vet. Immunol. Immunopathol. 2010, 137:76-83.
148. Schaffartzik A., Marti E., Torsteinsdottir S., Mellor P.S., Crameri R., Rhyner C. Selective cloning, characterization, and production of the Culicoides nubeculosus salivary gland allergen repertoire associated with equine insect bite hypersensitivity. Vet. Immunol. Immunopathol. 2011, 139:200-209.
149. Schelonka R.L., Infante A.J. Neonatal immunology. Semin. Perinatol. 1998, 22:2-14.
150. Schmallenbach K.H., Rahman I., Sasse H.H., Dixon P.M., Halliwell R.E., McGorum B.C., Crameri R., Miller H.R. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Vet. Immunol. Immunopathol. 1998, 66:245-256.
151. Schrenzel M.D., Ferrick D.A. Horse (Equus caballus) T-cell receptor alpha, gamma, and delta chain genes: nucleotide sequences and tissue-specific gene expression. Immunogenetics 1995, 42:112-122.
152. Schrenzel M.D., Watson J.L., Ferrick D.A. Characterization of horse (Equus caballus) T-cell receptor beta chain genes. Immunogenetics 1994, 40:135-144.
153. Schurink A., van der Meide N.M., Savelkoul H.F., Ducro B.J., Tijhaar E. Factors associated with Culicoides Obsoletus complex spp.-specific IgE reactivity in Icelandic horses and Shetland ponies. Vet. J. 2014, 395-400.
154. Shin E.K., Rijkers T., Pastink A., Meek K. Analyses of TCRB rearrangements substantiate a profound deficit in recombination signal sequence joining in SCID foals: Implications for the role of DNA-dependent protein kinase in V(D)J recombination. J. Immunol. 2000, 164:1416-1424.
155. Slater J. From glanders to Hendra virus: 125 years of equine infectious diseases. Vet. Rec. 2013, 173:186-189.
156. Slater J., Hannant D. Equine immunity to viruses. Vet. Clin. North Am. Equine Pract. 2000, 16:49-68.
157. Spencer N.D., Gimble J.M., Lopez M.J. Mesenchymal stromal cells: past, present, and future. Vet. Surg. 2011, 40:129-139.
158. Sponseller B.A., de Macedo M.M., Clark S.K., Gallup J.M., Jones D.E. Activation of peripheral blood monocytes results in more robust production of IL-10 in neonatal foals compared to adult horses. Vet. Immunol. Immunopathol. 2009, 127:167-173.
159. Steinbach F., Deeg C., Mauel S., Wagner B. Equine immunology: offspring of the serum horse. Trends Immunol. 2002, 23:223-225.
160. Strachan D.P. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000, 55(Suppl. 1):S2-S10.
161. Sun L., Gong Z., Oberst E.J., Betancourt A., Adams A.A., Horohov D.W. The promoter region of interferon-gamma is hypermethylated in neonatal foals and its demethylation is associated with increased gene expression. Dev. Comp. Immunol. 2013, 39:273-278.
162. Sun L.S., Adams A.A., Betancourt A., Stewart J.C., Liu C., Horohov D.W. The role of proliferation in the regulation of interferon gamma (IFN gamma) expression in foals. Dev. Comp. Immunol. 2012, 36:534-539.
163. Swiderski C.E., Klei T.R., Horohov D.W. Quantitative measurement of equine cytokine mRNA expression by polymerase chain reaction using target-specific standard curves. J. Immunol. Methods 1999, 222:155-169.
164. Takai S., Martens R.J., Julian A., Garcia Ribeiro M., Rodrigues de Farias M., Sasaki Y., Inuzuka K., Kakuda T., Tsubaki S., Prescott J.F. Virulence of Rhodococcus equi isolated from cats and dogs. J. Clin. Microbiol. 2003, 41:4468-4470.
165. Tanizaki Y., Kitani H., Okazaki M., Mifune T., Mitsunobu F., Okano T., Honke N., Kimura I. A new modified classification of bronchial asthma based on clinical symptoms. Intern. Med. 1993, 32:197-203.
166. Tisoncik J.R., Korth M.J., Simmons C.P., Farrar J., Martin T.R., Katze M.G. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 2012, 76:16-32.
167. Torres-Tortosa M., Arrizabalaga J., Villanueva J.L., Galvez J., Leyes M., Valencia M.E., Flores J., Pena J.M., Perez-Cecilia E., Quereda C. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases. Chest 2003, 123:1970-1976.
168. Tschetter J.R., Davis W.C., Perryman L.E., McGuire T.C. CD8 dimer usage on alpha beta and gamma delta T lymphocytes from equine lymphoid tissues. Immunobiology 1998, 198:424-438.
169. Tseng C.T., Miller D., Cassano J., Bailey E., Antczak D.F. Identification of equine major histocompatibility complex haplotypes using polymorphic microsatellites. Anim. Genet. 2010, 41(Suppl. 2):150-153.
170. Tsujimura K., Shiose T., Yamanaka T., Nemoto M., Kondo T., Matsumura T. Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain. J. Vet. Med. Sci. 2009, 71:1439-1448.
171. Van de Walle G.R., May M.A., Peters S.T., Metzger S.M., Rosas C.T., Osterrieder N. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. Vaccine 2010, 28:1048-1055.
172. van der Haegen A., Kunzle F., Gerber V., Welle M., Robinson N.E., Marti E. Mast cells and IgE-bearing cells in lungs of RAO-affected horses. Vet. Immunol. Immunopathol. 2005, 108:325-334.
173. van Maanen C., Cullinane A. Equine influenza virus infections: an update. Vet. Q. 2002, 24:79-94.
174. Vengust M., Staempfli H., Prescott J.F. Rhodococcus equi pleuropneumonia in an adult horse. Can. Vet. J. 2002, 43:706-708.
175. Viveiros M.M., Antczak D.F. Characterization of equine natural killer and IL-2 stimulated lymphokine activated killer cell populations. Dev. Comp. Immunol. 1999, 23:521-532.
176. Vychodilova L., Matiasovic J., Bobrova O., Futas J., Klumplerova M., Stejskalova K., Cvanova M., Janova E., Osickova J., Vyskocil M., Sedlinska M., Dusek L., Marti E., Horin P. Immunogenomic analysis of insect bite hypersensitivity in a model horse population. Vet. Immunol. Immunopathol. 2013, 152:260-268.
177. Wagner B. IgE in horses: occurrence in health and disease. Vet. Immunol. Immunopathol. 2009, 132:21-30.
178. Wagner B., Burton A., Ainsworth D. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory T(R)1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet. Res. 2010, 41.
179. Wagner B., Miller W.H., Morgan E.E., Hillegas J.M., Erb H.N., Leibold W., Antczak D.F. IgE and IgG antibodies in skin allergy of the horse. Vet. Res. 2006, 37:813-825.
180. Webbon P. Harnessing the genetic toolbox for the benefit of the racing Thoroughbred. Equine Vet. J. 2012, 44:8-12.
181. Wichtel M.G., Anderson K.L., Johnson T.V., Nathan U., Smith L. Influence of age on neutrophil function in foals. Equine Vet. J. 1991, 23:466-469.
182. Willoughby R., Ecker G., McKee S., Riddolls L., Vernaillen C., Dubovi E., Lein D., Mahony J.B., Chernesky M., Nagy E., et al. The effects of equine rhinovirus, influenza virus and herpesvirus infection on tracheal clearance rate in horses. Can. J. Vet. Res. 1992, 56:115-121.
183. Yamanaka T., Nemoto M., Tsujimura K., Kondo T., Matsumura T. Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses. Vet. Microbiol. 2009, 139:351-355.
184. Yao S., Qi J., Liu J., Chen R., Pan X., Li X., Gao F., Xia C. Expression, refolding and preliminary X-ray crystallographic analysis of equine MHC class I molecule complexed with an EIAV-Env CTL epitope. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2012, 68:20-23.
185. Ziegler-Heitbrock L. Monocyte subsets in man and other species. Cell. Immunol. 2014, 289:135-139.